Spore.Bio

Spore.Bio develops Louis, a label-free microbiology device that detects and quantifies bacteria, Total Viable Count and yeast and mold directly from a filtered sample. The website states results in about 10 minutes, without culture, enrichment or dyes, using a machine-learning analysis engine and a cloud dashboard for trend tracking.

The company targets quality teams in factories in the water and environment, beverages, cosmetics, pharmaceuticals, cell and gene therapy, and food industries. The website describes an early-adopter program and a sample consumable sold alongside the device; it does not describe pricing or revenue model details beyond this.

Spore.Bio was founded in 2023 in Paris, France, and its registered address is in Boulogne-Billancourt. The team page cites funding of $35M+ and a Series A round, and lists 2026 open roles in Paris across hardware, machine learning, software, microbiology and customer success.

Product: Louis, an AI-based benchtop microbiology device with a disposable filter capture module and a cloud dashboard for microbial data.